In a welcome move, MasTec saw its Relative Strength Rating improve from 69 to 73 on Monday.
IBD's unique rating tracks share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
History shows that the best stocks tend to have an RS Rating north of 80 as they begin their biggest climbs. See if MasTec can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock is able to form a base and break out.
MasTec saw both earnings and sales growth rise last quarter. Earnings-per-share increased from 72% to 136%. Revenue rose from 0% to 4%. The company is expected to report its latest numbers on or around May 1.
MasTec holds the No. 10 rank among its peers in the Building-Heavy Construction industry group. Argan, Construction Ptrs Cl A and Ferrovial are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
